The impact of IVF on deep invasive endometriosis

Nicola Berlanda, Laura Benaglia, Lara Bottelli, Chiara Torri, Andrea Busnelli, Edgardo Somigliana, Paolo Vercellini

Research output: Contribution to journalArticle

Abstract

Objective: Ovarian hyper-stimulation during IVF is associated with a significant raise in serum estrogens and one may expect detrimental effects on estrogen-dependent diseases such as endometriosis. However, available evidence from large case series of affected women performing IVF is generally reassuring with the possible exception of women carrying deep invasive lesions. On this basis we deemed important investigating more in depth whether women with deep invasive endometriosis could be a subgroup at higher risk of recurrence or disease progression during IVF. Study design: Women with endometriosis who underwent IVF and who had a second evaluation after 3–6 months from a failed cycle were retrospectively reviewed. The main inclusion criteria were the presence of deep invasive endometriosis and/or a history of surgery for this form of the disease. The primary aim of the study was to determine the frequency of endometriosis-related complications in the interval between the two evaluations. Secondary aims were pain symptoms and lesion size modifications. Results: Eighty-four women were ultimately selected: baseline ultrasound documented deep invasive lesions in 60 of them. One case of possible endometriosis-related complication was recorded, corresponding to a rate of 1.2% (95%: 0.05%–5.5%) for the whole cohort and 1.7% (95%CI: 0.08–7.6%) for the subgroup of women with ultrasound detected lesions. This rate appears similar to the reported frequency of endometriosis progression in women not receiving IVF. No significant modifications in pain symptoms or lesions size occurred. Conclusions: Women with deep invasive endometriosis who underwent IVF do not seem to be exposed to a substantially increased risk of recurrence/disease progression. Larger evidence from independent groups is however required for a definitive conclusion.

Original languageEnglish
Article number100073
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology: X
Volume4
DOIs
Publication statusPublished - Oct 1 2019

Fingerprint

Endometriosis
Disease Progression
Estrogens
Recurrence
Pain
Ovulation Induction
Serum

Keywords

  • Deep invasive endometriosis
  • IVF
  • Recurrence

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

The impact of IVF on deep invasive endometriosis. / Berlanda, Nicola; Benaglia, Laura; Bottelli, Lara; Torri, Chiara; Busnelli, Andrea; Somigliana, Edgardo; Vercellini, Paolo.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology: X, Vol. 4, 100073, 01.10.2019.

Research output: Contribution to journalArticle

@article{32ade754fbd449e0b755b987a097a619,
title = "The impact of IVF on deep invasive endometriosis",
abstract = "Objective: Ovarian hyper-stimulation during IVF is associated with a significant raise in serum estrogens and one may expect detrimental effects on estrogen-dependent diseases such as endometriosis. However, available evidence from large case series of affected women performing IVF is generally reassuring with the possible exception of women carrying deep invasive lesions. On this basis we deemed important investigating more in depth whether women with deep invasive endometriosis could be a subgroup at higher risk of recurrence or disease progression during IVF. Study design: Women with endometriosis who underwent IVF and who had a second evaluation after 3–6 months from a failed cycle were retrospectively reviewed. The main inclusion criteria were the presence of deep invasive endometriosis and/or a history of surgery for this form of the disease. The primary aim of the study was to determine the frequency of endometriosis-related complications in the interval between the two evaluations. Secondary aims were pain symptoms and lesion size modifications. Results: Eighty-four women were ultimately selected: baseline ultrasound documented deep invasive lesions in 60 of them. One case of possible endometriosis-related complication was recorded, corresponding to a rate of 1.2{\%} (95{\%}: 0.05{\%}–5.5{\%}) for the whole cohort and 1.7{\%} (95{\%}CI: 0.08–7.6{\%}) for the subgroup of women with ultrasound detected lesions. This rate appears similar to the reported frequency of endometriosis progression in women not receiving IVF. No significant modifications in pain symptoms or lesions size occurred. Conclusions: Women with deep invasive endometriosis who underwent IVF do not seem to be exposed to a substantially increased risk of recurrence/disease progression. Larger evidence from independent groups is however required for a definitive conclusion.",
keywords = "Deep invasive endometriosis, IVF, Recurrence",
author = "Nicola Berlanda and Laura Benaglia and Lara Bottelli and Chiara Torri and Andrea Busnelli and Edgardo Somigliana and Paolo Vercellini",
year = "2019",
month = "10",
day = "1",
doi = "10.1016/j.eurox.2019.100073",
language = "English",
volume = "4",
journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology: X",
issn = "2590-1613",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - The impact of IVF on deep invasive endometriosis

AU - Berlanda, Nicola

AU - Benaglia, Laura

AU - Bottelli, Lara

AU - Torri, Chiara

AU - Busnelli, Andrea

AU - Somigliana, Edgardo

AU - Vercellini, Paolo

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Objective: Ovarian hyper-stimulation during IVF is associated with a significant raise in serum estrogens and one may expect detrimental effects on estrogen-dependent diseases such as endometriosis. However, available evidence from large case series of affected women performing IVF is generally reassuring with the possible exception of women carrying deep invasive lesions. On this basis we deemed important investigating more in depth whether women with deep invasive endometriosis could be a subgroup at higher risk of recurrence or disease progression during IVF. Study design: Women with endometriosis who underwent IVF and who had a second evaluation after 3–6 months from a failed cycle were retrospectively reviewed. The main inclusion criteria were the presence of deep invasive endometriosis and/or a history of surgery for this form of the disease. The primary aim of the study was to determine the frequency of endometriosis-related complications in the interval between the two evaluations. Secondary aims were pain symptoms and lesion size modifications. Results: Eighty-four women were ultimately selected: baseline ultrasound documented deep invasive lesions in 60 of them. One case of possible endometriosis-related complication was recorded, corresponding to a rate of 1.2% (95%: 0.05%–5.5%) for the whole cohort and 1.7% (95%CI: 0.08–7.6%) for the subgroup of women with ultrasound detected lesions. This rate appears similar to the reported frequency of endometriosis progression in women not receiving IVF. No significant modifications in pain symptoms or lesions size occurred. Conclusions: Women with deep invasive endometriosis who underwent IVF do not seem to be exposed to a substantially increased risk of recurrence/disease progression. Larger evidence from independent groups is however required for a definitive conclusion.

AB - Objective: Ovarian hyper-stimulation during IVF is associated with a significant raise in serum estrogens and one may expect detrimental effects on estrogen-dependent diseases such as endometriosis. However, available evidence from large case series of affected women performing IVF is generally reassuring with the possible exception of women carrying deep invasive lesions. On this basis we deemed important investigating more in depth whether women with deep invasive endometriosis could be a subgroup at higher risk of recurrence or disease progression during IVF. Study design: Women with endometriosis who underwent IVF and who had a second evaluation after 3–6 months from a failed cycle were retrospectively reviewed. The main inclusion criteria were the presence of deep invasive endometriosis and/or a history of surgery for this form of the disease. The primary aim of the study was to determine the frequency of endometriosis-related complications in the interval between the two evaluations. Secondary aims were pain symptoms and lesion size modifications. Results: Eighty-four women were ultimately selected: baseline ultrasound documented deep invasive lesions in 60 of them. One case of possible endometriosis-related complication was recorded, corresponding to a rate of 1.2% (95%: 0.05%–5.5%) for the whole cohort and 1.7% (95%CI: 0.08–7.6%) for the subgroup of women with ultrasound detected lesions. This rate appears similar to the reported frequency of endometriosis progression in women not receiving IVF. No significant modifications in pain symptoms or lesions size occurred. Conclusions: Women with deep invasive endometriosis who underwent IVF do not seem to be exposed to a substantially increased risk of recurrence/disease progression. Larger evidence from independent groups is however required for a definitive conclusion.

KW - Deep invasive endometriosis

KW - IVF

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=85068159289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068159289&partnerID=8YFLogxK

U2 - 10.1016/j.eurox.2019.100073

DO - 10.1016/j.eurox.2019.100073

M3 - Article

AN - SCOPUS:85068159289

VL - 4

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology: X

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology: X

SN - 2590-1613

M1 - 100073

ER -